Titan Medical, Inc. announced today that it has signed a non-binding memorandum of understanding with Crouse Hospital, Inc., a 506-bed acute care hospital in Syracuse, NY. Under the terms of the agreement, Crouse Hospital will test and evaluate the company's Amadeus Next Generation Surgical Robotic Platform. Crouse Hospital will provide the Titan with detailed feedback as appropriate.
Dr. Reiza Rayman, President of Titan Medical, Inc., commented, "We are very excited to work closely with Crouse Hospital, a recognized pioneer in ambulatory surgery, in the pursuit of validating and advancing our next generation robotic surgical system into clinical trials."
Dr. David M. Albala, M.D., Chief of Urology at Crouse Hospital and Medical Director for Associated Medical Professionals, said, "This is an exciting development for robotic surgery in Central New York and it certainly speaks volumes about Crouse Hospital's commitment in advancing surgical technology as a means to deliver the best potential outcomes to the community. I am thrilled about the opportunity to be one of a few sites in the country that will perform further testing of Titan Medical's next generation robotic surgery system. My early testing of Titan's prototype platform has been very encouraging. The Titan system already delivers many improvements from our current system and I am optimistic that there is more to come."